Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens. - Moy B; Oliveira M; Saura C; Gradishar W; Kim SB; Brufsky A; Hurvitz SA; Ryvo L; Fagnani D; Kalmadi S; Silverman P; Delaloge S; et al. (Breast cancer research and treatment, 2021)